My Story of Into Bo • Large Platform ｜ Shan Guohong: Concern the "Old Friends" of the Expo

The autumn rain is moist, the autumn wind is cool, and the golden autumn September is ushered in. The pace of the Fifth Expo is getting closer and closer, and "My Entry Story" has also been known and concerned about more and more people. Friends who participated in the Expo and followed the Expo, and used their sharing to depict a "common memory" about the Expo.

On June 1st, we launched the "My Entrance Story" collection event, and in July and August, we published a number of outstanding works around the theme of "big strategy" and "big markets". In September, we will continue to share the "My Graduation Story" around the theme of the "big platform", telling the "overflow effect" of "exhibit products" and "exhibitors" and "exhibitors" and "exhibitors".

Let's hold the "Golden Key" of the Expo in the "Expo Story", to go to the golden autumn appointment to share the golden future!

Takeda Pharmaceutical Global Senior Vice President, President Takeda Chinese President

Single country

There is a deep relationship between Takeda Pharmaceutical and the Expo. It can be said to be very appropriate with the word "old friend". In the first four sessions, in addition to missed the acquisition integration in 2019 due to the regret of the acquisition and integration, the remaining three sessions went to the appointment as scheduled as old friends and participated in depth. For many years, Takeda has a deep understanding of the radiation and overflowing effect of the Expo platform, and with each year's enlistment, Takeda's strategic development level in the Chinese market has also been continuously improved.

I am very familiar with the Expo. After 4 years of tempering and sublimation, the role of the Expo platform has become more and more highlighted. I feel particularly deep in this -we have made the right choice!

The Expo is a high -quality platform for comprehensively displaying corporate image. In 2020, the completion of the acquisition of the integrated Takeda Pharmaceutical returned to the Expo. Employees are looking forward to showing the image of a stronger and larger new Takeda to the world through this global feast. Through the exhibition of Qianzhihe -shaped models, we expressed the beautiful wishes of the people of the world in the era of the epidemic. The "Public Health Epidemic Prevention Zone" established for the first time showed the experience, contributions and innovation results of all pharmaceuticals in the fight against the new crown epidemic, and became the most interesting area at that time. At this Expo, Takeda officially announced the "Wuju Future" of Takeda China's five -year development plan. By 2025, more than 15 innovative products were listed in China to benefit 10 million Chinese patients. It can be said that the implementation of the "Wuju Future" plan has promoted Wutian China to enter a new high -speed development cycle.

The Expo is an excellent platform for exchanges and cooperation closely. In addition to the most intuitive "highlights" of global high -quality exhibits, the Expo is surging and win -win cooperation. At the Fourth Expo, we worked with the partner of the biomedical industry ecosystem to bring more than 10 innovative cooperation project release activities. At the same time, intensive participation in high -end forums, medical insurance and drug supervision and other topic seminars and exchanges, as well as high -specification activities such as Pudong New District's relevant promotion conferences, actively provided suggestions for industry development and economic and trade exchanges. These forums and supporting activities have made all parties in the industry work more closely, helping to promote the development of the industry together, so that the platform of the Expo will continue to release it outward.

The Expo is an important platform for the continuous release of the overflow effect. National health and public health are important topics that governments at all levels, medical institutions, medical people, and even the whole society. At the 3rd Expo, Takeda brought 5 innovative products in rare diseases. Thanks to the overflowing effect of the Expo, in just half a year, these five products have been officially approved in China. In 2021, relevant national departments issued a series of policies to continue to promote industry innovation and high -quality development. Relying on this opportunity, Takeda China has a total of 3 new products approved throughout the year, including 2 rare disease areas and 1 innovative product in the field of lung cancer, accounting for about 1/3 of the total approval of Takeda, and these 3 products are these 3 products, and these 3 products are these 3 products. They have appeared at the Expo in the past two times. It can be said that the reason why we can achieve such a "Chinese speed" is closely related to the continuous optimization of the approval and review process and encouraging innovation, which is inseparable from the strong spillover effect of the Expo.

Takeda has always regarded China as one of the most important strategic markets in the world. Therefore, the past sessions, including our global CEO, and many global executives in Takeda participated in different ways. China's innovation environment and innovation opportunities have also been known by our overseas colleagues through the Expo. In this context, this year Takeda has officially implemented the "Tuowei China" strategy worldwide to fully tap China's potential to be the second largest pharmaceutical market in the world.

Accompanied with each other, growing side by side. Takeda Pharmaceutical expects to continue to compose the "old friend" of the Expo to allow global innovation achievements to introduce China at a faster speed, and also shows the potential of Chinese innovation to the world.

Shan Guohong is currently the senior vice president of Takeda Pharmaceutical and President of Takeda China. He is fully responsible for the overall strategy and business development of Takeda China. Earlier many times, Mr. Shan Guohong led the team to display the innovative drugs and breakthrough therapies in the core therapy field of Takeda, showing Takeda's determination and commitment to help "Healthy China". In the Fifth Expo, Mr. Shan Guo Hong will lead Takeda Pharmaceutical to the "Expo of the Expo."

Participate in the "My Entrance Story" solicitation:

inWhat kind of institutions have participated in, experience, witness, witness the dots of the previous Expo, or feel the changes brought about by the Expo to work or life. Welcome to tell us the story you experience or know.

- END -